Expert Presentations
Novel therapies in acute myeloid leukemia
Eunice Wang, MD
Jeffrey Lancet, MD
Curtis Lachowiez, MD
Eytan Stein, MD
Watch Time: 23 mins
Learn about the latest emerging research and promising advances in the treatment and management of acute myeloid leukemia (AML) presented at ASH 2020.
Expert Presentations
Measurable residual disease in acute lymphoblastic leukemia
Lori Muffly, MD, MS
Nicholas Short, MD
Josep-Maria Ribera, MD, PhD
Watch Time: 40 mins
Watch leading experts discuss recent data on the use and importance of measurable residual disease (MRD) assessment in guiding therapeutic decisions in patients with acute lymphoblastic leukemia (ALL) presented at ASH 2020.
